Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Abbreviation
HHSOIG
Agencies
Department of Health & Human Services
Federal Agency
Yes
Location

United States

What to Report to the OIG Hotline
The U.S. Department of Health and Human Services (HHS) Office of Inspector General's (OIG) mission is to protect the integrity of HHS programs as well as the health and welfare of program beneficiaries. In doing so, we rely on complaints by HHS employees, contractors, subcontractors, grantees and subgrantees (i.e. whistleblowers) who report fraud, waste, abuse or mismanagement in HHS programs. We also review and investigate reports of whistleblower retaliation. If you would like more information on what kinds of complaints our OIG investigates, please visit our website at https://oig.hhs.gov/fraud/report-fraud/before-you-submit.asp. There you will find a list of things you should know before submitting a complaint to the OIG. If you would like more information on the types of whistleblowers protected by the OIG, please visit our whistleblower protection page at https://oig.hhs.gov/fraud/report-fraud/whistleblower.asp. If you are a whistleblower and wish to report fraud, waste, abuse or mismanagement in HHS programs, or you wish to report whistleblower retaliation, please visit our Hotline at https://oig.hhs.gov/fraud/report-fraud/index.asp.
What Not to Report to the OIG Hotline
  • Issues about Medicare policy, coverage, billing claims or appeals
  • Lost or stolen Medicare card
  • Allegations by HHS employees of discrimination on the basis of race, gender, ethnicity, religion or sexual preference
  • Allegations by employees or applicants concerning prohibited personnel practices; or Hatch Act violations
  • Appeals of administrative decisions made by HHS agencies, grantees or contractors, including Medicare payment decisions and contract or grant awards
  • Appeals of judicial decisions by federal or state courts involving HHS programs
  • Complaints of failure to safeguard medical information, i.e. HIPAA violations
  • Customer service complaints involving HHS employees, grantees or contractors
  • Allegations of identity theft unrelated to HHS programs
  • Disability fraud
  • SNAP/Food Stamp Fraud
  • Self-Disclosures

Oversight of Opioid Prescribing and Monitoring of Opioid Use: States Have Taken Action To Address the Opioid Epidemic

2019
A-09-18-01005
Audit
Department of Health & Human Services OIG
Department of Health & Human Services

We identified actions that selected States took related to their oversight of opioid prescribing and their monitoring of opioid use. The selected States were Nebraska, Nevada, New Hampshire, Tennessee, Texas, Utah, Washington State, and West Virginia. This report summarizes and compares information...

The Food and Drug Administration Generally Complied With Federal Requirements for the Preparation and Receipt of Select Agent Shipments

2019
A-03-16-00354
Audit
Department of Health & Human Services OIG
Department of Health & Human Services

The Food and Drug Administration (FDA) is one of several Federal agencies that ship and receive select agents. Select agents are biological agents or toxins that HHS and the Department of Agriculture have determined pose a threat to humans, animals, plants, or the environment. In 2015, another...

Part D Plans Generally Include Drugs Commonly Used by Dual Eligibles: 2019

2019
OEI-05-19-00220
Inspection / Evaluation
Department of Health & Human Services OIG
Department of Health & Human Services

This report fulfills for 2019 the annual reporting mandate from the Patient Protection and Affordable Care Act (ACA). The ACA requires OIG to conduct a study of the extent to which formularies used by Medicare Part D plans include drugs commonly used by full benefit dual eligible individuals (i.e...

Medicare Part D Rebates for Prescriptions Filled at 340B Contract Pharmacies

2019
A-03-16-00002
Audit
Department of Health & Human Services OIG
Department of Health & Human Services

Congress created the 340B Drug Pricing Program to assist providers serving vulnerable patient populations by allowing them to purchase outpatient drugs at discounted prices. For drugs dispensed to Medicare Part D beneficiaries for payment under the Part D program, manufacturers may pay rebates based...

Safeguards Must Be Strengthened To Protect Medicare Hospice Beneficiaries From Harm

2019
OEI-02-17-00021
Inspection / Evaluation
Department of Health & Human Services OIG
Department of Health & Human Services

This report describes specific instances of harm to hospice beneficiaries and identifies vulnerabilities in CMS's efforts to prevent and address harm. In past work, the Office of Inspector General (OIG) raised a number of concerns about the care provided to Medicare beneficiaries. As part of a...

Hospice Deficiencies Pose Risks to Medicare Beneficiaries

2019
OEI-02-17-00020
Inspection / Evaluation
Department of Health & Human Services OIG
Department of Health & Human Services

The Office of Inspector General (OIG) has identified significant vulnerabilities in the Medicare hospice benefit and found that hospices did not always provide needed services to beneficiaries and sometimes provided poor quality care. Hospice care can provide great comfort to beneficiaries, their...

New York Claimed Federal Reimbursement for Some Payments to Health Home Providers That Did Not Meet Medicaid Requirements

2019
A-02-17-01004
Audit
Department of Health & Human Services OIG
Department of Health & Human Services

The Medicaid "health home" option allows States to create programs that provide care coordination and care management for beneficiaries with chronic health conditions. Health homes are not physical spaces. Rather, they are a health care model in which providers work together to coordinate and manage...

New York's Claims for Medicaid Nursing Home Transition and Diversion Waiver Program Services Generally Complied With Federal and State Requirements but Had Reimbursement Errors That Resulted in a Minimal Amount of Overpayments

2019
A-02-17-01005
Audit
Department of Health & Human Services OIG
Department of Health & Human Services

During a prior review, we determined that New York claimed Medicaid reimbursement for home and community-based services (HCBS) under a Medicaid waiver program that did not comply with Federal requirements.New York's Nursing Home Transition and Diversion (NHTD) is an HCBS waiver program. Our...

Problems Remain for Ensuring That All High Risk Medicaid Providers Undergo Criminal Background Checks

2019
OEI-05-18-00070
Inspection / Evaluation
Department of Health & Human Services OIG
Department of Health & Human Services

An effective provider enrollment screening process is an important tool for preventing Medicaid fraud. It plays a vital role in identifying unscrupulous providers and preventing them from enrolling in Medicaid. The Federal Government requires States to conduct risk based screening activities as part...

Opioid Use Decreased in Medicare Part D, While Medication-Assisted Treatment Increased

2019
OEI-02-19-00390
Inspection / Evaluation
Department of Health & Human Services OIG
Department of Health & Human Services

The Nation has been grappling with an opioid crisis for several years. In 2017 alone, there were 47,600 opioid-related overdose deaths in the United States. It continues to be a public health emergency. OIG has been tracking opioid use in Medicare during this crisis, particularly since 2016. OIG has...

Subscribe to Department of Health & Human Services OIG